Pivotal phase II data presented for murlentamab in metastatic colorectal adenocarcinoma July 10, 2019
Trovagene initiates enrollment in phase Ib/II study of onvansertib in mCRC with KRAS mutation July 10, 2019
EIP Pharma initiates phase II study of neflamapimod for the treatment of cognitive deficits in HD July 10, 2019